Tom Fromm

Vice President of Sales at Telix Pharmaceuticals

[Toni Choueiri, MD @DrChoueiri]

#ZIRCON study by @KidneyCancerDoc
Zr-DFO-girentuximab: anti-CAIX antibody based imaging showing promising results in detecting ccRCC:
PPV 93% NPV 75% with similar results for small renal masses
#GU23 @OncoAlert

[Sirtex Medical @SirtexMedical]

📅 Mark your calendars for Tues, 7/26 at 8 p.m. EST!

Dr. @danbrownIO will walk through the first publication of the U.S. RESiN registry for #mCRC reporting efficacy outcomes, like overall survival, from almost 500 patients. Details here: https://t.co/QfNOTLk2dw #LearnAtSirtex

[Sirtex Medical @SirtexMedical]

You're invited to . . . An Evening of Case Reviews and Discussions.✨

Next Monday (7/25), Dr. Zachary Collins and Dr. @AdamAlliMD1 will discuss the SIR-Spheres® Advantage in a virtual event you won't want to miss. #LearnAtSirtex

Register here: https://t.co/NflLZrnRZ7

[Sirtex Medical @SirtexMedical]

💥 NEW Webinar on 7/26 at 8 p.m. EST 💥

You won't want to miss Dr. @danbrownIO covering the current status of #Y90 Radioembolization of #mCRC based on his award-winning abstract! Sign up here: https://t.co/QfNOTLBD54

[Sirtex Medical @SirtexMedical]

Our partnership with @Mimsoftware advances innovation and increases precision of liver-directed oncology therapies.

Visit our new website to learn more about INSYTE with SurePlan™ Liver #Y90: https://t.co/vVQwib9TnI

[Dan Brown @danbrownIO]

Our 498 patient colorectal cancer study assessing Y90 survival by line of therapy is online @radiology_rsna

15 month median OS for all patients
17.4 months as part of 2nd line therapy
12.5 months as salvage

#CRC #RESiN @ecemmons @VUMCradiology
https://t.co/FvOQE3e7UN

[Sirtex Medical @SirtexMedical]

Happening Monday 6/13: The Muscle your FLEX Symposium!

#SIR22BOS attendees, clear your schedules from 12 - 1 p.m. EST to join Dr. David Liu (@iryvr), Dr. @NimaKokabiMD, Dr. @SabinaAminMD and Dr. Ripal Gandhi for an engaging discussion on the #FLEXdose Delivery Program.

[Sirtex Medical @SirtexMedical]

It's good to be back at #SIR22BOS!

Here's where you can find all the Sirtex key activities going on this week, including hands-on workshops, live demonstrations, presentations & more. @SIRSpecialists

[Tom Fromm @tom_fromm]

Looking forward to a great event at #GEST2022!

[Sirtex Medical @SirtexMedical]

Attending #GEST2022?

Visit the NY East Ballroom on 5/19 for a Sirtex Symposium led by Dr. @ahmed_kamel_ir where he will be discussing how SIR-Spheres® #Y90 resin microspheres can improve patient outcomes.

Registration info here: https://t.co/JcRXiE7f9Z

[Sirtex Medical @SirtexMedical]

Check this out: @OncLive featured Dr. @JeyarajahRohan in a recent article and interview.

Be sure to read for his expert point of view on how SIR-Spheres® #Y90 resin microspheres can be best leveraged to improve #mCRC outcomes. https://t.co/q2jeIgvRFF

[Sirtex Medical @SirtexMedical]

There is no better place than #SIO2022 for the latest updates in #InterventionalOncology. The Sirtex team has enjoyed meeting so many industry professionals and sharing insights on the future of noninvasive #oncology solutions.

Visit booth 3 to join us! @SIO_Central

[Sirtex Medical @SirtexMedical]

SIO attendees, grab your seat for our symposium 🎟

Who: Dr. @NimaKokabiMD
What: Symposium on #Y90 in mCRC
When: Tomorrow, Saturday 3/26 at 12:30 p.m. EST
Where: #SIO2022 @SIO_Central
Registration: https://t.co/dutyuQATJy

[Sirtex Medical @SirtexMedical]

Hello #SIO2022 attendees! Visit booth 3 to learn more about the speed, flexibility & knowledge that comes with The SIR-Spheres® Advantage & register for our symposium happening on 3/26 with guest speaker @NimaKokabiMD

Register: https://t.co/dutyuQATJy @SIO_Central

[Sirtex Medical @SirtexMedical]

In 2012, Suzanne was diagnosed with stage 4 #colorectalcancer. After several treatments, the cancer reappeared in her liver and she turned to SIR-Spheres® #Y90 resin microspheres, inspiring more hope in her than ever before.

#SIRSpheresSurvivor #CRCAwarenessMonth @CCAlliance

[Sirtex Medical @SirtexMedical]

BIG NEWS: SIR-Spheres® #Y90 resin microspheres has received NDA approval in China for the treatment of #colorectalcancer liver metastases.

Read more about this milestone accomplishment and what it means for our global mission: https://t.co/moO0eXnvWv #mCRC #ChooseRESiN

[Rohan Jeyarajah @JeyarajahRohan]

Pls join this webinar I am doing on Monday re a new algorithm for the use of resin y90 in MCRC

https://t.co/d6BAZ52YnH

[Sirtex Medical @SirtexMedical]

#IRads, don't forget to register for our next installment of #LearnAtSirtex:

Who: Dr. Rohan Jeyarajah, MD, FACS (@JeyarajahRohan)
When: 12/6 at 5PM CT
Where: https://t.co/tSTIBDOOSq
Why: To give physicians a look into integrating #Y90 into the mCRC surgical pathway

[Sirtex Medical @SirtexMedical]

The #DOORwaY90 study will be the first U.S. registration trial to utilize & delineate personalized #dosimetry treatment planning. We look forward to working with Dr. @ArmeenMahvash during this impactful clinical trial. Read more here: https://t.co/gzE7f72Gmw #HCC #Y90

[Sirtex Medical @SirtexMedical]

New webinar alert! Join us Mon. 12/6 from 5-7 p.m. CT for the latest installment of #LearnAtSirtex. Dr. Rohan Jeyarajah, MD, FACS (@JeyarajahRohan) will be discussing best practices for integrating #Y90 into the #mCRC pathway.

Register today: https://t.co/tSTIBDOOSq